Detection and characterization of MuSK antibodies in seronegative myasthenia gravis
Top Cited Papers
- 22 March 2004
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 55 (4) , 580-584
- https://doi.org/10.1002/ana.20061
Abstract
Antibodies to rat muscle specific kinase, MuSK, have recently been identified in some generalized “seronegative” myasthenia gravis (SNMG) patients, who are often females with marked bulbar symptoms. Using immunoprecipitation of 125I‐labelled‐human MuSK, 27 of 66 (41%) seronegative patients were positive, but 18 ocular SNMG patients, 105 AChR antibody positive MG patients, and 108 controls were negative. The antibodies are of high affinity (Kds around 100 pM) with titers between 1 and 200 nM. They bind to the extracellular Ig‐like domains of soluble or native MuSK. Surprisingly they are predominantly in the IgG4 subclass. MuSK‐antibody associated MG may be differnet in etiological and pathological mechanisms.Keywords
This publication has 18 references indexed in Scilit:
- Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravisBrain, 2003
- A radioimmunoprecipitation assay for antibodies to botulinum ANeurology, 1998
- Clinical heterogeneity of seronegative myasthenia gravisNeuromuscular Disorders, 1996
- Receptor tyrosine kinase specific for the skeletal muscle lineage: Expression in embryonic muscle, at the neuromuscular junction, and after injuryNeuron, 1995
- A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.Proceedings of the National Academy of Sciences, 1995
- Passive transfer of seronegative myasthenia gravis to miceMuscle & Nerve, 1994
- Seronegative generalized myasthenia gravisNeurology, 1992
- Seronegative myasthenia gravis: Clinical features, response to therapy and synthesis of acetylcholine receptor antibodies in vitroJournal of the Neurological Sciences, 1991
- Characterization of the human cell line TE671Carcinogenesis: Integrative Cancer Research, 1989
- MYASTHENIA GRAVIS WITHOUT ACETYLCHOLINE-RECEPTOR ANTIBODY: A DISTINCT DISEASE ENTITYThe Lancet, 1986